We are live on ! Find out more
RPID icon

Rapid Micro Biosystems

53 hedge funds and large institutions have $82.8M invested in Rapid Micro Biosystems in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 5253 (+1)

1.3% less ownership

Funds ownership: 71.75%70.45% (-1.3%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

26% less capital invested

Capital invested by funds: $112M → $82.8M (-$29.3M)

44% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 18

Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
0.91%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
9
Increased
10
Reduced
18
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CCM
26
CAAS Capital Management
New York
$119K
MF
27
Magnetar Financial
Illinois
$113K +$24K +6,190 +21%
Goldman Sachs
28
Goldman Sachs
New York
$97K -$91.4K -23,549 -44%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$96K -$252 -65 -0.2%
State Street
30
State Street
Massachusetts
$84K
AGM
31
Alpine Global Management
New York
$84K +$101K +25,919 New
PL
32
Parkwood LLC
Ohio
$79K
GCP
33
GSA Capital Partners
United Kingdom
$74K -$26.3K -6,780 -23%
Northern Trust
34
Northern Trust
Illinois
$69K +$660 +170 +0.8%
Morgan Stanley
35
Morgan Stanley
New York
$67K -$54.5K -14,034 -40%
TSS
36
Two Sigma Securities
New York
$66K +$79.3K +20,441 New
RA
37
Royce & Associates
New York
$58K +$69.5K +17,900 New
TRCT
38
Tower Research Capital (TRC)
New York
$56K +$29.7K +7,645 +79%
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$43K +$912 +235 +2%
SSA
40
Schonfeld Strategic Advisors
New York
$40K +$9.7K +2,500 +25%
VA
41
Valmark Advisers
Ohio
$36K +$43.1K +11,101 New
Tudor Investment Corp
42
Tudor Investment Corp
Connecticut
$35K +$41.8K +10,760 New
BFM
43
Boothbay Fund Management
New York
$33K -$33.6K -8,671 -46%
Bank of America
44
Bank of America
North Carolina
$13K +$7.86K +2,025 +100%
UBS Group
45
UBS Group
Switzerland
$6K -$9.97K -2,569 -55%
Citigroup
46
Citigroup
New York
$2K -$34.4K -8,869 -94%
RMC
47
Resources Management Corp
Connecticut
$2K
Osaic Holdings
48
Osaic Holdings
Arizona
$2K +$147 +38 +5%
CUAMC
49
China Universal Asset Management Company
China
$1K +$1.32K +341 New
IV
50
Industry Ventures
California
-$1.24M -287,502 Closed

RPID Hedge Fund Activity: Q3 2022 in Review

53 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q3 2022, worth a combined $82.8M — down 26% from $112M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new RPID positions and 8 closed out — a net gain of 1 holder — while 10 added to existing stakes and 18 trimmed.

The largest buyer was Vanguard Group, adding an estimated $193K. The largest seller was T. Rowe Price Associates, cutting an estimated $10M.

  • 53 institutional investors held Rapid Micro Biosystems (RPID) as of Q3 2022, up from 52 in Q2 2022.
  • Funds reported $82.8M of Rapid Micro Biosystems stock for Q3 2022, down 26% quarter-over-quarter.
  • 9 funds opened new Rapid Micro Biosystems positions in Q3 2022 and 8 closed out, a net change of +1 holder.
  • The largest Rapid Micro Biosystems buyer in Q3 2022 was Vanguard Group, an estimated $193K added.
  • The largest Rapid Micro Biosystems seller in Q3 2022 was T. Rowe Price Associates, an estimated $10M sold.

Based on aggregated 13F filings for Q3 2022.